PhoenixBio Co., Ltd. (TYO:6190)

PhoenixBio Statistics

Total Valuation

PhoenixBio has a market cap or net worth of JPY 2.01 billion. The enterprise value is 1.30 billion.

Market Cap	2.01B
Enterprise Value	1.30B

Important Dates

The last earnings date was Friday, February 13, 2026.

Earnings Date	Feb 13, 2026
Ex-Dividend Date	n/a

Share Statistics

PhoenixBio has 4.07 million shares outstanding. The number of shares has decreased by -0.59% in one year.

Current Share Class	4.07M
Shares Outstanding	4.07M
Shares Change (YoY)	-0.59%
Shares Change (QoQ)	+0.05%
Owned by Insiders (%)	20.22%
Owned by Institutions (%)	6.35%
Float	1.63M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.26
PB Ratio	1.33
P/TBV Ratio	1.34
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-6.33
EV / Sales	0.81
EV / EBITDA	11.87
EV / EBIT	16.41
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.22, with a Debt / Equity ratio of 0.22.

Current Ratio	4.22
Quick Ratio	3.22
Debt / Equity	0.22
Debt / EBITDA	3.10
Debt / FCF	n/a
Interest Coverage	15.80

Financial Efficiency

Return on equity (ROE) is -12.87% and return on invested capital (ROIC) is 9.69%.

Return on Equity (ROE)	-12.87%
Return on Assets (ROA)	2.10%
Return on Invested Capital (ROIC)	9.69%
Return on Capital Employed (ROCE)	4.37%
Weighted Average Cost of Capital (WACC)	5.02%
Revenue Per Employee	23.16M
Profits Per Employee	-2.97M
Employee Count	69
Asset Turnover	0.68
Inventory Turnover	0.84

Taxes

In the past 12 months, PhoenixBio has paid 19.00 million in taxes.

Income Tax	19.00M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +35.36% in the last 52 weeks. The beta is 0.26, so PhoenixBio's price volatility has been lower than the market average.

Beta (5Y)	0.26
52-Week Price Change	+35.36%
50-Day Moving Average	488.96
200-Day Moving Average	436.14
Relative Strength Index (RSI)	47.61
Average Volume (20 Days)	30,695

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, PhoenixBio had revenue of JPY 1.60 billion and -205.00 million in losses. Loss per share was -50.78.

Revenue	1.60B
Gross Profit	1.25B
Operating Income	79.00M
Pretax Income	-186.00M
Net Income	-205.00M
EBITDA	109.25M
EBIT	79.00M
Loss Per Share	-50.78

Balance Sheet

The company has 1.05 billion in cash and 339.00 million in debt, with a net cash position of 714.00 million or 175.42 per share.

Cash & Cash Equivalents	1.05B
Total Debt	339.00M
Net Cash	714.00M
Net Cash Per Share	175.42
Equity (Book Value)	1.52B
Book Value Per Share	372.46
Working Capital	1.25B

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 78.41%, with operating and profit margins of 4.94% and -12.83%.

Gross Margin	78.41%
Operating Margin	4.94%
Pretax Margin	-11.64%
Profit Margin	-12.83%
EBITDA Margin	6.84%
EBIT Margin	4.94%
FCF Margin	n/a

Dividends & Yields

PhoenixBio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.59%
Shareholder Yield	0.59%
Earnings Yield	-10.20%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

PhoenixBio has an Altman Z-Score of 1.76 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.76
Piotroski F-Score	4